Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19Jun‐Hyung Cho, Jang‐Hoon Choi|Scientific Reports|2020Cited by 99
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected miceJu Hwan Jeong, Min‐Suk Song, Ok-Jun Lee et al.|Antiviral Research|2022Cited by 82
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected miceJu Hwan Jeong, Min‐Suk Song, Santosh Chokkakula et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 10
Evaluating Z-FA-FMK, a host cathepsin L protease inhibitor, as a potent and broad-spectrum antiviral therapy against SARS-CoV-2 and related coronavirusesJu Hwan Jeong, Min‐Suk Song, Jang‐Hoon Choi et al.|Antiviral Research|2023Cited by 7